We are live on ! Find out more
ProShare Advisors

ProShare Advisors Portfolio holdings

AUM $67.5B
1-Year Est. Return 28.09%
This Fund
S&P 500
This Quarter Est. Return
-12.35%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$14.3B
AUM Growth
-$444M
Cap. Flow
+$1.68B
Cap. Flow %
11.73%
Top 10 Hldgs %
21.62%
Holding
1,821
New
56
Increased
555
Reduced
957
Closed
250

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$101M
2
AMZN icon
Amazon
AMZN
+$99.5M
3
MSFT icon
Microsoft
MSFT
+$95.8M
4
LIN icon
Linde
LIN
+$84.2M
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$40.4M

Sector Composition

Rank Sector Weight
1 Technology 19.27%
2 Healthcare 13.08%
3 Financials 12.21%
4 Consumer Discretionary 10.94%
5 Consumer Staples 10.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SYRS
1501
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$78K ﹤0.01%
+1,407
New +$107K
AUD
1502
DELISTED
Audacy, Inc.
AUD
$77K ﹤0.01%
13,491
-2,175
-14% -$14.5K
VTLE
1503
DELISTED
Vital Energy
VTLE
$75K ﹤0.01%
1,033
-112
-10% -$11.8K
ACCO icon
1504
Acco Brands
ACCO
$369M
$74K ﹤0.01%
10,905
-1,759
-14% -$15.1K
MNKD icon
1505
MannKind Corp
MNKD
$1.28B
$73K ﹤0.01%
68,853
-10,670
-13% -$18.1K
PRTK
1506
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$73K ﹤0.01%
14,212
-2,579
-15% -$19.6K
MCRB icon
1507
Seres Therapeutics
MCRB
$48M
$72K ﹤0.01%
801
-157
-16% -$22K
SYBX
1508
DELISTED
Synlogic
SYBX
$72K ﹤0.01%
+683
New +$89.9K
SBBP
1509
DELISTED
Strongbridge Biopharma plc.
SBBP
$72K ﹤0.01%
15,995
-3,054
-16% -$14.9K
AMKR icon
1510
Amkor Technology
AMKR
$16.1B
$71K ﹤0.01%
10,784
-1,738
-14% -$11.5K
SPN
1511
DELISTED
Superior Energy Services, Inc.
SPN
$70K ﹤0.01%
2,077
-1,094
-35% -$76K
OCUL icon
1512
Ocular Therapeutix
OCUL
$1.86B
$69K ﹤0.01%
+17,445
New +$96.2K
DNTH icon
1513
Dianthus Therapeutics
DNTH
$5.68B
$66K ﹤0.01%
+728
New +$99.2K
KA
1514
DELISTED
Kineta, Inc. Common Stock
KA
$66K ﹤0.01%
+145
New +$98.3K
FOMX
1515
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
$66K ﹤0.01%
18,399
+1,771
+11% +$7.7K
KALA icon
1516
KALA BIO
KALA
$11.8M
$64K ﹤0.01%
5
INFN
1517
DELISTED
Infinera Corporation Common Stock
INFN
$63K ﹤0.01%
15,893
-2,561
-14% -$12.8K
EYPT icon
1518
EyePoint Inc
EYPT
$1.02B
$61K ﹤0.01%
+3,215
New +$77.8K
NBR icon
1519
Nabors Industries
NBR
$1.23B
$60K ﹤0.01%
598
-272
-31% -$59.9K
ASNA
1520
DELISTED
Ascena Retail Group, Inc.
ASNA
$60K ﹤0.01%
1,194
-125
-9% -$8.84K
COGT icon
1521
Cogent Biosciences
COGT
$6.79B
$53K ﹤0.01%
+3,038
New +$89.9K
HLIT icon
1522
Harmonic Inc
HLIT
$1.21B
$53K ﹤0.01%
11,204
-1,152
-9% -$6.29K
GPRO icon
1523
GoPro
GPRO
$116M
$51K ﹤0.01%
12,108
-1,712
-12% -$9.58K
OPCH icon
1524
Option Care Health
OPCH
$3.4B
$48K ﹤0.01%
3,333
-537
-14% -$7.08K
TLPH icon
1525
Talphera
TLPH
$70.1M
$48K ﹤0.01%
+1,049
New +$70.2K

Similar funds

ProShare Advisors's Q4 2018 Portfolio in Review

As of Q4 2018, ProShare Advisors held 1,821 positions worth $14.3B, down 3% from $14.7B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

ProShare Advisors deployed $1.68B of net new capital in Q4 2018, opening 56 new positions and adding to 555 existing holdings. Its largest new stake was Linde: 532,831 shares worth $83.1M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 19% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was McCormick & Company Non-Voting, an estimated $14.7M trimmed.

  • ProShare Advisors's largest Q4 2018 buy was Linde: 532,831 shares worth $83.1M.
  • ProShare Advisors added most to Apple in Q4 2018, an estimated $101M increase.
  • ProShare Advisors's biggest Q4 2018 reduction was McCormick & Company Non-Voting, cutting an estimated $14.7M.
  • ProShare Advisors fully exited Praxair Inc in Q4 2018, selling an estimated $77.4M.
  • ProShare Advisors's ten largest holdings make up 22% of its $14.3B portfolio in Q4 2018.
  • ProShare Advisors opened 56 new positions and closed 250 in Q4 2018.
  • ProShare Advisors's portfolio value fell 3% quarter-over-quarter to $14.3B.

Based on ProShare Advisors's 13F filing for Q4 2018, filed 14 Feb 2019.